Share-based Payment Arrangement, Noncash Expense of Twist Bioscience Corp from 30 Sep 2017 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount of noncash expense for share-based payment arrangement.
- Summary
-
Twist Bioscience Corp quarterly and annual Share-based Payment Arrangement, Noncash Expense in USD history and change rate from 30 Sep 2017 to 31 Dec 2025.
- Twist Bioscience Corp Share-based Payment Arrangement, Noncash Expense for the quarter ending 31 Dec 2025 was $13,273,000, a 11% increase year-over-year.
- Twist Bioscience Corp annual Share-based Payment Arrangement, Noncash Expense for 2025 was $64,459,000, a 27% increase from 2024.
- Twist Bioscience Corp annual Share-based Payment Arrangement, Noncash Expense for 2024 was $50,925,000, a 68% increase from 2023.
- Twist Bioscience Corp annual Share-based Payment Arrangement, Noncash Expense for 2023 was $30,278,000, a 62% decline from 2022.
- Source SEC data
- View on sec.gov
Share-based Payment Arrangement, Noncash Expense, Quarterly (USD)
Share-based Payment Arrangement, Noncash Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Noncash Expense, Annual (USD)
Share-based Payment Arrangement, Noncash Expense, YoY Annual Change (%)
Twist Bioscience Corp Quarterly Share-based Payment Arrangement, Noncash Expense (USD)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $13,273,000 | +$1,282,000 | +11% | 01 Oct 2025 | 31 Dec 2025 | 10-Q/A | 26 Feb 2026 | 2026 | Q1 | |
| Q4 2024 | $11,991,000 | +$971,000 | +8.8% | 01 Oct 2024 | 31 Dec 2024 | 10-Q/A | 26 Feb 2026 | 2026 | Q1 | |
| Q4 2023 | $11,020,000 | +$13,345,000 | 01 Oct 2023 | 31 Dec 2023 | 10-Q | 03 Feb 2025 | 2025 | Q1 | ||
| Q4 2022 | $2,325,000 | -$20,433,000 | -113% | 01 Oct 2022 | 31 Dec 2022 | 10-Q | 02 Feb 2024 | 2024 | Q1 | |
| Q4 2021 | $18,108,000 | +$11,086,000 | +158% | 01 Oct 2021 | 31 Dec 2021 | 10-Q | 07 Feb 2023 | 2023 | Q1 | |
| Q4 2020 | $7,022,000 | +$3,325,000 | +90% | 01 Oct 2020 | 31 Dec 2020 | 10-Q | 09 Feb 2022 | 2022 | Q1 | |
| Q4 2019 | $3,697,000 | +$1,833,000 | +98% | 01 Oct 2019 | 31 Dec 2019 | 10-Q | 09 Feb 2021 | 2021 | Q1 | |
| Q4 2018 | $1,864,000 | +$1,328,000 | +248% | 01 Oct 2018 | 31 Dec 2018 | 10-Q | 10 Feb 2020 | 2020 | Q1 | |
| Q4 2017 | $536,000 | 01 Oct 2017 | 31 Dec 2017 | 10-Q | 11 Feb 2019 | 2019 | Q1 |
Twist Bioscience Corp Annual Share-based Payment Arrangement, Noncash Expense (USD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $64,459,000 | +$13,534,000 | +27% | 01 Oct 2024 | 30 Sep 2025 | 10-K | 17 Nov 2025 | 2025 | FY |
| 2024 | $50,925,000 | +$20,647,000 | +68% | 01 Oct 2023 | 30 Sep 2024 | 10-K | 17 Nov 2025 | 2025 | FY |
| 2023 | $30,278,000 | -$49,386,000 | -62% | 01 Oct 2022 | 30 Sep 2023 | 10-K | 17 Nov 2025 | 2025 | FY |
| 2022 | $79,664,000 | +$42,666,000 | +115% | 01 Oct 2021 | 30 Sep 2022 | 10-K | 18 Nov 2024 | 2024 | FY |
| 2021 | $36,998,000 | +$19,902,000 | +116% | 01 Oct 2020 | 30 Sep 2021 | 10-K | 21 Nov 2023 | 2023 | FY |
| 2020 | $17,096,000 | +$5,926,000 | +53% | 01 Oct 2019 | 30 Sep 2020 | 10-K/A | 05 Jun 2023 | 2022 | FY |
| 2019 | $11,170,000 | +$8,209,000 | +277% | 01 Oct 2018 | 30 Sep 2019 | 10-K | 23 Nov 2021 | 2021 | FY |
| 2018 | $2,961,000 | +$1,070,000 | +57% | 01 Oct 2017 | 30 Sep 2018 | 10-K | 27 Nov 2020 | 2020 | FY |
| 2017 | $1,891,000 | 01 Oct 2016 | 30 Sep 2017 | 10-K | 13 Dec 2019 | 2019 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.